160 related articles for article (PubMed ID: 32016619)
1. pH- and acoustic-responsive platforms based on perfluoropentane-loaded protein nanoparticles for ovarian tumor-targeted ultrasound imaging and therapy.
Li J; Ji H; Jing Y; Wang S
Nanoscale Res Lett; 2020 Feb; 15(1):31. PubMed ID: 32016619
[TBL] [Abstract][Full Text] [Related]
2. Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
Yang D; Chen Q; Zhang M; Feng G; Sun D; Lin L; Jing X
Int J Nanomedicine; 2022; 17():4879-4894. PubMed ID: 36262190
[TBL] [Abstract][Full Text] [Related]
3. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-Loaded Nanoparticles with Low-Intensity Focused Ultrasound-Induced Phase Transformation as Tumor-Targeted and pH-Sensitive Theranostic Nanoplatform of Ovarian Cancer.
Guo X; Mei J; Jing Y; Wang S
Nanoscale Res Lett; 2020 Apr; 15(1):73. PubMed ID: 32266591
[TBL] [Abstract][Full Text] [Related]
5. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
[TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
7. Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging.
Liu J; Shang T; Wang F; Cao Y; Hao L; Ren J; Ran H; Wang Z; Li P; Du Z
Int J Nanomedicine; 2017; 12():911-923. PubMed ID: 28184161
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
[TBL] [Abstract][Full Text] [Related]
9. Enhanced HIFU Theranostics with Dual-Frequency-Ring Focused Ultrasound and Activatable Perfluoropentane-Loaded Polymer Nanoparticles.
Chen J; Nan Z; Zhao Y; Zhang L; Zhu H; Wu D; Zong Y; Lu M; Ilovitsh T; Wan M; Yan K; Feng Y
Micromachines (Basel); 2021 Oct; 12(11):. PubMed ID: 34832737
[TBL] [Abstract][Full Text] [Related]
10. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
[TBL] [Abstract][Full Text] [Related]
11. Study on Contrast-Enhanced Ultrasound Imaging and Anti-Tumor Effects of Drug-Loaded Nanodroplets with Tumor Targeting and Ultrasound Sensitivity.
Li Y; Chen Y; Liu R; Duan S; Chen L; Sun J; Zhang L
Front Biosci (Landmark Ed); 2023 Jun; 28(6):115. PubMed ID: 37395016
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-mediated delivery of RGD-conjugated nanobubbles loaded with fingolimod and superparamagnetic iron oxide nanoparticles: targeting hepatocellular carcinoma and enhancing magnetic resonance imaging.
Guo XM; Chen JL; Zeng BH; Lai JC; Lin CY; Lai MY
RSC Adv; 2020 Oct; 10(64):39348-39358. PubMed ID: 35518389
[TBL] [Abstract][Full Text] [Related]
13. Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy.
Zhu L; Zhao H; Zhou Z; Xia Y; Wang Z; Ran H; Li P; Ren J
Nano Lett; 2018 Mar; 18(3):1831-1841. PubMed ID: 29419305
[TBL] [Abstract][Full Text] [Related]
14. Dual ultrasound-activatable nanodroplets for highly-penetrative and efficient ovarian cancer theranostics.
Yang C; Zhang Y; Luo Y; Qiao B; Wang X; Zhang L; Chen Q; Cao Y; Wang Z; Ran H
J Mater Chem B; 2020 Jan; 8(3):380-390. PubMed ID: 31868193
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells.
Zou X; Li T; Mao Y; Zhu M; Chen X; Niu J; Dong T; Jiang J; Yang X
Biomed Res Int; 2022; 2022():6441179. PubMed ID: 36411770
[No Abstract] [Full Text] [Related]
16. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
[TBL] [Abstract][Full Text] [Related]
17. Stable Low-Dose Oxygen Release Using H
Jiang N; Hu B; Cao S; Gao S; Cao Q; Chen J; Zhou Q; Guo R
Ultrasound Med Biol; 2020 Oct; 46(10):2765-2774. PubMed ID: 32646686
[TBL] [Abstract][Full Text] [Related]
18. Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity.
Li M; Zhu Y; Yang C; Yang M; Ran H; Zhu Y; Zhang W
Drug Deliv; 2022 Dec; 29(1):2177-2189. PubMed ID: 35815688
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-Triggered Phase-Transition Cationic Nanodroplets for Enhanced Gene Delivery.
Gao D; Xu M; Cao Z; Gao J; Chen Y; Li Y; Yang Z; Xie X; Jiang Q; Wang W; Liu J
ACS Appl Mater Interfaces; 2015 Jun; 7(24):13524-37. PubMed ID: 26016606
[TBL] [Abstract][Full Text] [Related]
20. Development of Drug Dual-Carriers Delivery System with Mitochondria-Targeted and pH/Heat Responsive Capacity for Synergistic Photothermal-Chemotherapy of Ovarian Cancer.
Guo X; Mei J; Zhang C
Int J Nanomedicine; 2020; 15():301-313. PubMed ID: 32021181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
